Latest Market Intelligence
Latest Market Intelligence
Global Medtech CDMO Market: H1 2026 M&A Update
This update offers an overview of recent M&A activity, geographic distribution of transactions, target manufacturing capabilities, and data on target end-markets.Rare Disease Trial Recruitment: The Role of Patient Registries
Rare disease trials often face recruitment challenges that traditional site-led models are not built to solve. In this interview, our experts discuss how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.
Clinical Trial Excellence in 2026: Managing the Complexity of Modern Clinical Development
Adaptive methodologies, biomarker-driven strategies, decentralized models, and AI-powered analytics are driving a structural shift in clinical development. These advances expand what is scientifically and operationally possible, and introduce new layers of complexity, risk, and executional pressure. This interview discusses what these changes mean for biotech decision-makers.From Approval to Adoption: A New Framework for Medtech Success
Today, medtech success requires more than approval. In this Q&A, our expert explores how a more integrated approach that aligns patient needs, evidence generation, and market access from the outset can result in improved commercial outcomes.
Serving Life Science Clients Globally
Improving the Life of Every Patient
We firmly believe that patient voices must be heard. By bridging our clients and patient advocacy groups, we empower patients to help the healthcare industry deliver what they value most in their care. We facilitate true and fruitful interactions that serve stakeholders across the ecosystem and benefit all patients.
~ Annabel de Maria
Chief Patient Officer
Let us tell you more about how our solutions bridge clinical research with routine medical care to